| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/25/2009 | CN100464566C Method and equipment of changed digital color image |
| 02/25/2009 | CN100463916C Preparation of hemsleyadine-A and its use of preparing pharmaceutics against cancers |
| 02/25/2009 | CN100463908C Substituted 8' -pyridinyl-dihydrospiro- [cycloalkyl] -pyrimido [1,2-a] pyrimidin-6-one and 8' -pyrimidinyl-dihydrospiro- [cycloalky]l -pyrimido p1,2-a] pyrimidin-6-one derivatives |
| 02/25/2009 | CN100463906C Extraction method for daphnoretin |
| 02/25/2009 | CN100463694C Virus coat protein/receptor chimeras and methods of use |
| 02/25/2009 | CN100463688C Ointment with aloe and other five medicinal herbs and its preparation method |
| 02/25/2009 | CN100463681C Artificial tears for treating xerophthalmia |
| 02/25/2009 | CN100463680C Composition comprising soluble glucan oligomer from saccharomyces cerevisiae IS2 inhibiting the swine influenza (SIV) and transmissible gastroenteritis coronavirus (TGEV) |
| 02/25/2009 | CN100463679C Clarithromycin soft capsule and its preparation |
| 02/25/2009 | CN100463678C Ifosfamide compositions for parenteral administration and a process for their preparation |
| 02/25/2009 | CN100463677C Preparation of nedaplatin freeze-dried powder injection |
| 02/25/2009 | CN100463676C Control releasing venlafaxine hydrochloride tablet and its preparation |
| 02/25/2009 | CN100463675C Soluble slow release external applied contraceptive |
| 02/25/2009 | CN100463674C Oral cavity quick dissolved film containing civeran and method for preparing the same |
| 02/25/2009 | CN100463673C Compound medicine release controlling film of chitosan, sodium alginate and gelatin and its preparing process |
| 02/25/2009 | CN100463670C Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same |
| 02/25/2009 | CN100463669C Self-emulsifying agent of compound artemether |
| 02/25/2009 | CN100463666C Composition for external use on skin |
| 02/24/2009 | US7495127 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity; pimaric acid, dihydropimaric acid, dihydroisopimarinol, sandaracopimaric acid, isopimaric acid, and dihydroisopimaric acid |
| 02/24/2009 | US7495114 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/24/2009 | US7495111 Compounds useful as serotonin inhibitors and 5-HT1A agonists and antagonists |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495108 Imidazoline derivatives having CB1-antagonistic activity |
| 02/24/2009 | US7495107 Method for manufacturing isoxazole derivative or dihydroisoxazole derivative |
| 02/24/2009 | US7495105 dissolving in solvent, adding resolution agent and water, refluxing, cooling, stirring, then filtering; anesthetics; cardiovascular disorders |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495103 including cystic fibrosis transmembrane conductance regulator ("CFTR"), used for treating genetic disorders; respiratory system disorders |
| 02/24/2009 | US7495099 Polyethylene glycol-polyglutamic acid block copolymer conjugates with e.g. 7-ethyl-10-hydroxycamptothecin or topotecan for sustained release; water solubility, anticancer agents |
| 02/24/2009 | US7495088 Nuclease resistant nucleotide capable of hybridizing with complementary RNA in a manner which inhibits function of the RNA |
| 02/24/2009 | US7495086 TWEAK receptor |
| 02/24/2009 | US7495030 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
| 02/24/2009 | US7495029 (2R) 2-propyloctanoic acid esterified, amidated, or salified with a moiety which when released modulates biochemical events during a stroke, such as a cyclooxygenase-2 (COX-2) inhibitor |
| 02/24/2009 | US7495028 R-bambuterol, its preparation and therapeutic uses |
| 02/24/2009 | US7495027 drugs that inhibit biosynthesis of bacterial cell walls, such as (5Z)-5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one, used for treatment of bacterial infections, and as parasiticides |
| 02/24/2009 | US7495026 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
| 02/24/2009 | US7495025 Antimalarial agents; multidrug-resistant malaria; e.g. [3-(1-Phenyl-vinyl)-1,2,5-trioxa-spiro[5.5]undec-9-ylidene]-acetic acid ethyl ester |
| 02/24/2009 | US7495024 Use of e.g. N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea (ABT-761, Atreleuton) |
| 02/24/2009 | US7495023 treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis; also inhibiting cathepsins B and L to treat cancer; e.g. 3'-Bromopropiophenone Thiosemicarbazone |
| 02/24/2009 | US7495022 α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| 02/24/2009 | US7495021 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/24/2009 | US7495019 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 02/24/2009 | US7495018 An enzyme inhibitor of p38 MAP kinase, an antagonist of tumor necrosis factors or adenosine receptor, a thiazole with the 5-pyridyl group derivatives |
| 02/24/2009 | US7495017 3-(3-Cyclopentyloxy-4-methoxyphenyl)-1H-pyrazole;adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease |
| 02/24/2009 | US7495016 inhibiting HIV replication in a cell; inhibiting reverse transcriptase |
| 02/24/2009 | US7495015 Inhibitors of p38 Mitogen-activated protein kinases (MAP kinases); arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, chronic obstructive pulmonary disease, Alzheimer's disease; 6-(2-Fluoro-phenoxy)-3-phenyl-1H-indazole for example |
| 02/24/2009 | US7495014 Gyrase inhibitors and uses thereof |
| 02/24/2009 | US7495013 Chemokine receptor modulators or Histamine H1 antagonists; autoimmune, inflammatory, proliferative or hyperproliferative diseases, or immune diseases; Methyl 4-[[4-(2,4dichloro-3-methylphenoxy)-1-piperidinyl]methyl]-alpha-(phenylmethyl)-1-piperidineacetate for example |
| 02/24/2009 | US7495012 Arylsulfonamides and uses related thereto |
| 02/24/2009 | US7495011 Anti-coronavirus drug |
| 02/24/2009 | US7495010 Muscarinic acetylcholine receptor antagonists |
| 02/24/2009 | US7495009 Imidazopyridine derivatives as melancortin receptor agonists |
| 02/24/2009 | US7495008 Spiro-piperidine derivatives |
| 02/24/2009 | US7495007 Spiroindolinone derivatives |
| 02/24/2009 | US7495006 reverse transcriptase (polymerase) inhibitor; viricide, antiproliferative agent; Retroviridae (including HIV), Hepadnaviridae (including HBV), or Flaviviridae (including BVDV and HCV) infection, AIDS |
| 02/24/2009 | US7495005 Antidiabetic agents; antiarthritic agents; obesity; graft verses host disease; osteoporosis |
| 02/24/2009 | US7495004 Purine derivatives as liver X receptor agonists |
| 02/24/2009 | US7495003 e.g. 1-(naphthyl-1-ylmethyl)-3-(methoxycarbonylmethyl)-7-(but-2-ynyl)-8-(3-amino-piperidin-1-yl)-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
| 02/24/2009 | US7495002 e.g. 1-[(3-methyl-isoquinolin- 1 -yl)methyl]-3-methyl-7-(2-butyn- 1 -yl)-8-[(2-amino-ethyl) -methylamino]-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
| 02/24/2009 | US7495001 Benzannelated derivatives, their manufacture and use as pharmaceutical agents |
| 02/24/2009 | US7495000 Variolin derivatives and their use as antitumor agents |
| 02/24/2009 | US7494999 Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| 02/24/2009 | US7494998 Benzisoxazole piperazine compounds and methods of use thereof |
| 02/24/2009 | US7494997 excellent BCR-ABL tyrosine kinase inhibitory activity; to treat leukemias; 3-bromo-4-(4-methylpiperazin-1-ylmethyl)-N-{4-methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]phenyl}benzamide; compounds with cell growth inhibitory effect |
| 02/24/2009 | US7494995 Phenylpyridylpiperazine compounds |
| 02/24/2009 | US7494994 Phenylpyridylpiperazine compounds |
| 02/24/2009 | US7494993 Enhanced activity, decreased toxicity, better solubility and improved pharmacokinetic profile; for inflammatory, immunological, CNS disorders, oncological disorders, bone diseases; Cyclohexanecarboxylic acid (4-chloro-3-{7-amino-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl}-phenyl)-amide |
| 02/24/2009 | US7494992 Antiparasitic terpene alkaloids |
| 02/24/2009 | US7494991 For microbial infections specially Gram-positive bacterial infection; atherosclerosis-associated disease |
| 02/24/2009 | US7494990 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/24/2009 | US7494988 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 02/24/2009 | US7494987 compounds with potent antitussive actions, high safety and less adverse actions; methyl 4-({1-[2-(4-cyanophenyl)ethyl]-3-hydroxyazetidin-3-ylmethyl}methylamino)benzoate |
| 02/24/2009 | US7494986 central nervous system disorders like Depression, anxiety, cognition enhancer, antiinflammatory agents; 4-((3,5-bis(trifluoromethyl)benzyloxy)methyl)-4-phenylazocane |
| 02/24/2009 | US7494985 Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
| 02/24/2009 | US7494984 Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors |
| 02/24/2009 | US7494983 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye |
| 02/24/2009 | US7494982 Modified oligonucleotides for telomerase inhibition |
| 02/24/2009 | US7494981 Inhibition of interaction of PSD93 and PSD95 with nNOS and NMDA receptors |
| 02/24/2009 | US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/24/2009 | US7494950 Implantable, specific aspect ratio (length/diameter) from about 50:1 to about 1000:1; flexural strength, flexural toughness, and/or screw pullout strength; calcium phosphate |
| 02/24/2009 | US7494824 Interactive system for presenting and eliminating substances |
| 02/24/2009 | US7494680 Fat or oil composition |
| 02/24/2009 | US7494674 Nutraceutical with tart cherries and method of treatment therewith |
| 02/24/2009 | US7494668 "auxiliary" granulate obtained by wet granulation of D-mannitol and maize starch gum in a high shear granulator, microcrystalline cellulose, a sweetener, a flavoring agent and a lubricant; pleasant taste and the absence of perceptible granules in the mouth |
| 02/24/2009 | US7494666 Administering to a mammal a formualtion comprising cationic lipids/DNA complex, allowing the complex to associate with angiogenic endothelial cells of an angiogenic blood vessel for a time such that the complex enters the target cells |
| 02/24/2009 | US7494660 HCV NS3-NS4A protease resistance mutants |
| 02/24/2009 | US7494642 Fatty acid derivatives; tissue-targeted therapy; tomography; cardiovascular disorders; liver disorders; kits |
| 02/24/2009 | US7494503 Method and apparatus for acne prevention |
| 02/24/2009 | CA2471338C Use of deoxypeganine for treating clinical depression |
| 02/24/2009 | CA2469813C Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 02/24/2009 | CA2468370C Chronic, bolus administration of d-threo methylphenidate |
| 02/24/2009 | CA2462741C Dry liposomal pvp-iodine compositions |
| 02/24/2009 | CA2444208C Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
| 02/24/2009 | CA2443543C Supplementation of equine feedstuffs |
| 02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2417361C New phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 02/24/2009 | CA2416109C Solid dose nanoparticulate compositions |